Characterization and prediction of IVF cycles generating "slow-cleaving" embryos
- PMID: 7633167
- DOI: 10.1007/BF02215709
Characterization and prediction of IVF cycles generating "slow-cleaving" embryos
Abstract
Purpose: To characterize and predict cycles generating open quote slow-cleaving closed quote embryos in in vitro fertilization, 86 cycles were retrospectively divided into two groups (open quote slow, closed quote n=41, and open quote fast, closed quote n=45) according to whether the number of blastomeres per embryo on day 3 was < or = or > than the mean of the distribution, respectively.
Results: Cycles generating open quote slow-cleaving closed quote embryos were treated with luteinizing hormone-releasing hormone agonist before ovarian stimulation for a shorter period (12.1 +/- 0.5 versus 15.6 +/- 1.1 days; P < or = 0.01) and had higher immaturity grade of oocyte-corona-cumulus complexes which resulted in embryos (1.6 +/- 0.1 vs 1.3 +/- 0.1; P < or = 0.05) when compared to cycles producing "fast-cleaving" embryos. Both variables entered in a logistic regression model applied in order to predict the probability of a cycle generating "slow-cleaving" embryos (goodness-of-fit chi-square = 180.0, degrees of freedom (df) = 80, P = 0.4786). This model predicted correctly 86.7% (13 of 15) of cycles generating "slow-cleaving" embryos and 83.3% (10 of 12) of cycles producing "fast-cleaving" embryos when the estimated probability of a cycle producing "slow-cleaving embryos" was > or = 0.7 or < or = 0.3, respectively.
Conclusion: Shorter treatment with hormone-releasing hormone agonist before ovarian stimulation and higher immaturity grade of oocyte- corona-cumulus complexes which result in embryos are predictive characteristics of in vitro fertilization cycles generating "slow-cleaving" embryos.
Similar articles
-
Sex ratio of babies is unchanged after transfer of fast- versus slow-cleaving embryos.J Assist Reprod Genet. 1995 Oct;12(9):566-8. doi: 10.1007/BF02212575. J Assist Reprod Genet. 1995. PMID: 8580650
-
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.Hum Reprod. 1997 Nov;12(11):2359-65. doi: 10.1093/humrep/12.11.2359. Hum Reprod. 1997. PMID: 9436663
-
Multinucleation in normally fertilized embryos is associated with an accelerated ovulation induction response and lower implantation and pregnancy rates in in vitro fertilization-embryo transfer cycles.Fertil Steril. 1998 Jul;70(1):60-6. doi: 10.1016/s0015-0282(98)00100-9. Fertil Steril. 1998. PMID: 9660422 Clinical Trial.
-
Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.Int J Gynaecol Obstet. 2008 Aug;102(2):203-16. doi: 10.1016/j.ijgo.2008.01.007. Int J Gynaecol Obstet. 2008. PMID: 18773532 Review.
-
Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD002808. doi: 10.1002/14651858.CD002808.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD002808. doi: 10.1002/14651858.CD002808.pub3 PMID: 15674898 Updated. Review.
References
MeSH terms
Substances
LinkOut - more resources
Miscellaneous